A novel peptide inhibits the influenza virus replication by preventing the viral attachment to the host cells. by Rajik, Mohamed et al.
A novel peptide inhibits the influenza virus replication by preventing the viral 
attachment to the host cells. 
 
ABSTRACT 
Avian influenza viruses (AIV), the causative agent of avian flu or bird flu, cause widespread 
morbidity and mortality in poultry. The symptoms of the disease range from mild flu like 
symptoms to death. These viruses possess two important surface glycoproteins, namely 
hemagglutinin (HA) and neuraminidase (NA) against which neutralizing antibodies are pro-
duced. Due to the highly mutative nature of the genes which encode these proteins, the vi-
ruses often confer resistance to the current anti-viral drugs making the prevention and 
treatment of infection challenging. In our laboratory, we have recently identified a novel anti-
viral peptide (P1) against the AIV H9N2 from a phage displayed peptide library. This peptide 
inhibits the replication of the virus in ovo and in vitro by its binding to the HA glyco-protein. 
In the current study, we demonstrate that the peptide inhibits the virus replication by 
preventing the attachment to the host cell but it does not have any effect on the viral fusion. 
The reduction in the viral nucleoprotein (NP) expression inside the host cell has also been 
observed during the peptide (P1) treatment. This novel peptide may have the potential to be 
developed as a therapeutic agent for the treatment and control of avian influenza virus H9N2 
infections. 
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